Rna Diagnostics
Toronto
About Rna Diagnostics
Rna Diagnostics is an early-stage molecular diagnostics company developing medical diagnostic tools to assist in the management of cancer. The company's first product, the RNA Disruption AssayTM (RDATM), is a novel test that helps oncologists rapidly assess the effectiveness of cancer chemotherapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2019)
- Website: rnadiagnostics.com
Industries & Categories
Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/rna-diagnostics-1495 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.